You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small Cell Lung Cancers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

Not yet recruiting
  • Lung Cancer
  • Gastro-intestinal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 9, 2023

NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Jun 26, 2023

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

Completed
  • Carcinoma, Non-small Cell Lung
  • Changsha, Hunan, China
    Hunan province tumor hospital
Mar 1, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Fairfax, Virginia
    NEXT Virginia
Feb 1, 2023

NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Kashiwa, Chiba, Japan
  • +3 more
Jan 31, 2023

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

Terminated
  • Head and Neck Cancer
  • +7 more
  • Tumor Profiling
  • Scottsdale, Arizona
  • +2 more
Dec 2, 2022

Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • EGFR Gene Mutation
  • Gemcitabine platinum combined with erlotinib
  • Changsha, Hunan, China
    Hunan Province Tumor Hospital
Feb 28, 2022

Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Sep 9, 2022

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

NSCLC, Solid Tumor Trial in Boston (Merestinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Solid Tumor
  • Boston, Massachusetts
  • +1 more
Jan 26, 2022

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Integrated Molecular Profiling in Advanced Cancers Trial

Active, not recruiting
  • Breast Cancer
  • +9 more
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    Sep 26, 2022

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • +2 more
    • Indianapolis, Indiana
    • +8 more
    May 5, 2023

    Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

    Active, not recruiting
    • Metastatic
    • +4 more
    • Radiotherapy
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 6, 2023

    Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

    Active, not recruiting
    • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 4, 2022

    NSCLCs Trial in Louisville (stereotactic ablative radiotherapy (SABR), Pentoxifylline)

    Recruiting
    • Non-small Cell Lung Cancers
    • Louisville, Kentucky
      James Graham Brown Cancer Center, U of Louisville
    Jun 21, 2021

    NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +10 more
    • Singapore, Singapore
      Novartis Investigative Site
    Nov 16, 2022

    Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

    Recruiting
    • Advanced Colorectal Carcinoma
    • +15 more
    • Fermented Wheat Germ Extract
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jul 26, 2023

    Blood, Urine, and Bone Marrow

    Recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • Test for circulating tumor cells, DNA alterations
    • Columbia, Missouri
      Harry S Truman Veterans Memorial Hospital
    Oct 31, 2022